1.
Senturk Yikilmaz A, Akinci S, Bakanay S, Dilek İmdat. VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience. Int J Hematol Oncol Stem Cell Res. 2020;14(4):248-256.